129764786880781250_265Business, March 16-a new Medicare drug prices to begin soon.
Mainstream pharmaceutical shares fell sharply in early, may indicate that the market has perceived the pharmaceutical industry will be faced with the policy adjustments, and many other factors, one of which is the national development and Reform Commission has recently made it clear that will start a new round of Medicare drug pricing scheme. On March 4, the prices of national development and Reform Commission, Division Director of pharmaceutical pricesSong Dacai confirmed that the national basic medical insurance and commercial insurance drug list (hereinafter referred to as "healthcare directory"), some products will continue to cut this month.
New health care directory, old medicine than health care directory, with greater scope for price, there will be greater price. Four major categories of drug price said Song Dacai, this price cut, antineoplastic agents, immune regulation classDrugs, blood products and medication will be the focus of the digestive system, a total of 216 species, these drugs may not at the same time prices. Round of Medicare drug pricing in the directory on March 28, 2011, 162 species within the national development and Reform Commission lowered health care directory, nearly 1300 forms specification maximum retail prices of medicines. Resistance to infection and cardiovascularDisease cycle of antibiotics and drugs focused on price, average drop to adjust front 21%; canceled more than 20 varieties of both priced separately. This price reduction, 27th the price of development and Reform Commission on drug price management history.
According to the previous prices average drop in-15%, some of the highest-ever drug even up to about 60%. ForThe reduction of problem, Song Dacai gave no exact figures for the average fall of the final, saying only in the different principles and methods can only be determined after. Experts believe that the single focus on the price
diablo 3 gold, such as anticancer drugs, blood products are higher priced varieties, so this round of the fall would exceed the previous year against infection and cardiovascular drugs 21% averageFall.
According to people familiar with the matter said, in fact, at the end of February, national development and Reform Commission in Tianjin and provincial and municipal departments in charge of drug prices discussed the new round of adjustment of Medicare drug prices, held subsequently convened the scope of small enterprises to communicate, hammer out a new round of price adjustment programmes. According to meeting requirements, development and Reform Commission will increase to high drug prices, and also submitted to high drugOverlay increases the decline on the basis of the requirements of the drop. Mainly, the high cost of high prices is high prices for drugs, formulations, new catalog yet to four classes of drugs, and the highest average retail prices and bid-ask spreads than the larger variety, overlay increases fall under different circumstances. In this analysis, separately priced, as well as original research and medicine in the past, usually outside the price range of drugs also fled without a dropPrice of blobs. Lisa Zou essence securities chief analyst said this projected price is actually a continuing adjustment of the 2011 Medicare directory, tone is expected to cut prices and last year close to the decline in average at around 20%, biggest drop of up to 40%, patented drugs is estimated to be around 5% per cent, and in order to further reduce the price of drugs in the same differences, foreign patentsDrug this fall is expected in the period 10%.
Meeting to discuss the general idea that, qualified to compete for larger product the lowest cut, minimum drop at 5%, the competition small set of maximum cut, Max is set to 40%. Price adjustment according to a participation in the meeting of experts, the price is: to bid in a productPrice difference between national pricing and compare sorted according to confirmation of a brand drug for high or low price drugs, considering circulation, hospital costs, factory, wholesale, sale price is five factors, through reference scales and of different varieties of cut calculation method to determine the specific enterprise. In fact, as early as 2010, the then Secretary for national development and Reform Commission prices medicine pricesLong Guo Jianying media interview, has said that government drug production costs and market adjustment to be considered actual transaction prices and other factors
diablo 3 power leveling, and to distinguish between different situations, highlight. Price under the Act, the drug administration law and the implementing regulations for the law of drug administration, three against drug pricing in China: Government pricing
diablo 3 power leveling, price guide and the Government of independent pricingIncluded in drugs and a small number of basic medical insurance claims directory has the monopoly of production and management of medicines, Government pricing or the Government price. In early 2010, development and Reform Commission, conducted a survey into healthcare directory of drug prices, requires Enterprise reported price data for three years, at the reference prices in the sector around the registration price, list price, priority provincesCity Hospital purchasing price, as well as large corporate transaction price. From the above discussion programme, followed the above adjustment, if, say, 2011 price adjustments have not seen significant market-oriented thinking, the more clearly the context of marketization of price adjustment. The price the product price as the most important indicator of national pricing and strongAdjustable narrow pricing products individually and the price difference of generic drug products, is a very big change. "In fact, the last price you have seen a number of different ideas, in addition to the abolition of separate pricing, according to the actual use of the different types of clinical need for price adjustment is also a thought. "Chinese medicine (600,056, market information, the major trading) corporateMingde Yu, President of the Association, for varieties with varieties of domestic enterprises and foreign-funded, joint venture spreads over problem, an important aspect will be the next adjustment. Enterprises limited impact if the industry as a whole, the bid prices fixed by Government as an important reference, enterprise market practices will have an important impact in the future. Comparison of foreign-funded enterprises in forming a unified view was:Medicine prices will result in profit margins further compression of the product. First vote in bidding policy of enterprise product strategies and marketing strategies will be most directly affected.
Bid price for each product in the future, will affect the whole industry the same Generic Drug Pricing behavior of Government, such as malicious bidding could lead to fatal blow to similar products. At the same time, the Conference also identifiedNew health insurance without pricing of medicines, to measure the market average retail price as the current bid price.
Then it means that enterprises have to enter health care directory to the possible price of drugs between the loss and the Medicare expansion of gains and losses made to reassess. However, analysts believe that the price on the influence of pharmaceutical companies may not have the market is so big. EMC CorporationI analyst Lisa Zou believed that key indicators of major current business profits or the bid price, and most of the non-exclusive medicine because of market competition, the tender price is far lower than the maximum retail price set by the State, does not impact on corporate earnings, and exclusive varieties as the maximum retail price and the bid price is often spread not, therefore subject to price a greater impact, but if it is only expected in the industry 5% Decline, businesses can afford. Shenyin wanguo Luo Juan also agreed with the view, senior analyst. She says, the real factors that affect the price of drugs is tender, tender prices determined by the market, competitive price drop, less competition is price stability.
Prior to the development and Reform Commission cut the retail price, bid price as competitive, in fact, has reduced significantly. According to an unwilling to disclose the names of the industrySay, medicine prices, drug companies is not entirely a bad thing, as into healthcare, sales tend to increase.
Hengrui docetaxel, for example, in 2004 included health care, sold less than 100 million at that time, prices have fallen by more than half, but sales have reached 1 billion. Known fact is that drug into the hospital sales to go through the provinces ofTender and domestic enterprises in the generic drug competitive, most variety in the actual list price is far lower than the maximum retail price by national development and Reform Commission. There is an argument that, prices are determined by market competition, and pharmaceuticals as the entrants increased, prices will fall, maybe that is why the Commission's thinking. Business if you want to be competitive, appears to be in research and developmentBitter efforts. Online statement Gold: gold online reprint of the above content, does not indicate that confirm the description, for investors ' reference only and does not constitute investment advice. Investor operations accordingly, at your own risk.
Others:
没有评论:
发表评论